Evidence map›Paper›PMID 41816654›Full record

ArticleFrontiers in medicine2026

The World Health Organization Coalition of Interested Parties Network: a unified and coordinated approach to regulatory system strengthening.

Andrea Keyter, Tariro Sithole, Alireza Khadem Broojerdi, Jude Nwokike, Martin Harvey-Allchurch, Hiiti Sillo

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea KeyterWorld Health Organization, Geneva, Switzerland.
Tariro SitholeWorld Health Organization Liaison Office to the African Union & UNECA, Addis Ababa, Ethiopia.
Alireza Khadem BroojerdiWorld Health Organization, Geneva, Switzerland.
Jude NwokikeUnited States Pharmacopeial Convention, Maryland, MD, United States.
Martin Harvey-AllchurchEuropean Medicines Agency, Amsterdam, Netherlands.
Hiiti SilloWorld Health Organization, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strong and effective regulatory systems are essential for achieving universal health coverage and ensuring access to safe, effective and quality-assured medical products. Yet, many countries have not yet achieved a well-functioning, stable and integrated regulatory system, with capacity gaps continuing to hinder the performance of national regulatory authorities. In response, the World Health Organization developed the Five-Step Capacity Building Model to guide and strengthen regulatory systems and the Global Benchmarking Tool, and further established the Coalition of Interested Parties (CIP) Network as a global coordination mechanism to unify and optimize regulatory system strengthening support. This manuscript describes the development, operationalization and measurable impact of the CIP Network, which has grown to include 33 active members, including leading global donors, development agencies and technical partners. Between 2023 and 2025, the CIP Network facilitated over USD 235 million in targeted investment and coordinated nearly 600 technical activities across more than 50 countries. Anchored by WHO's Global Benchmarking Tool and the implementation of Institutional Development Plans (IDPs), the Network operationalizes support through country-led coordination, shared visibility of priorities, continuous communication and accountability tracking. Member contributions span all regulatory functions, enabling rapid deployment of context-specific technical expertise. Regional and country-level case studies illustrate the transformative effect of this approach, demonstrating regulatory system strengthening, accelerated IDP implementation and maturity-level progression within a short timeframe. The CIP Network's structured, scalable and country-driven model exemplifies how coordinated, evidence-informed and partner-aligned mechanisms can deliver sustainable improvements in regulatory performance, serving as a blueprint for global regulatory strengthening.

Indexed as

coalition of interested parties (CIP) Networkglobal benchmarking tool (GBT)national regulatory authority (NRA)regulation of medical productsregulatory systems strengthening (RSS)

Identifiers

PMID41816654
PMCPMC12971434

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.